This combination product provides investigators with a pre-formulated blend of thymosin beta-4 fragment (TB-500) and Body Protection Compound-157 (BPC-157), enabling studies that examine potential synergistic or additive interactions between these two mechanistically distinct peptide sequences in a single experimental system
As featured in Glutathione is a naturally occurring antioxidant, often referred to as the bodys master antioxidant
Studies comparing combination protocols to single-peptide therapy show consistently superior outcomes: faster healing with 30 to 50 percent reduction in recovery time, more complete tissue regeneration, reduced inflammation, and improved patient-reported outcomes
BPC-157 supports this function by modulating inflammatory pathways, promoting microvascular regeneration, and accelerating epithelial turnover
These medicines have well-characterised safety profiles and are prescribed within a structured clinical pathway that includes monitoring and follow-up